Biological action of leptin as an angiogenic factor

Science

Volumn 281, Issue 5383, 1998, Pages 1683-1686

  Sierra Honigmann, M Rocío ^a   Nath, Anjali K ^a   Murakami, Chiaki ^a   García Cardeña, Guillermo ^a,d   Papapetropoulos, Andreas ^a   Sessa, William C ^a   Madge, Lisa A ^a   Schechner, Jeffrey S ^a   Schwabb, Michael B ^a   Polverini, Peter J ^b   Flores Riveros, Jaime R ^c,e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c BAYER CORPORATION   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Institute for Diagnostic Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; LEPTIN; LEPTIN RECEPTOR;

ARTICLE; CELL CULTURE; CORNEA NEOVASCULARIZATION; ENDOTHELIUM CELL; ENERGY EXPENDITURE; FOOD INTAKE; HORMONE ACTION; HORMONE RELEASE; HUMAN; HUMAN CELL; HYPOTHALAMUS; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

ADIPOCYTES; AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; CORNEAL NEOVASCULARIZATION; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENERGY METABOLISM; HUMANS; LEPTIN; LIPID METABOLISM; LYMPHOKINES; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTEINS; RATS; RATS, ZUCKER; RECEPTORS, CELL SURFACE; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032508682     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.281.5383.1683     Document Type: Article

References (39)

1. J. S. Flier, Proc. Natl. Acad. Sci. U.S.A. 94, 4242 (1997); N. Levin, C. Nelson, A. Gurney, R. Vandlen, F. de Sauvage, ibid. 93, 1726 (1996); M. A. Pelleymounter et al., Science 269, 540 (1995); J. L. Halaas et al., ibid., p. 543; L. A. Campfield, F. J. Smith, Y. Guisez, R. Devos, P. Burn, ibid., p. 546.
2. J. S. Flier, Proc. Natl. Acad. Sci. U.S.A. 94, 4242 (1997); N. Levin, C. Nelson, A. Gurney, R. Vandlen, F. de Sauvage, ibid. 93, 1726 (1996); M. A. Pelleymounter et al., Science 269, 540 (1995); J. L. Halaas et al., ibid., p. 543; L. A. Campfield, F. J. Smith, Y. Guisez, R. Devos, P. Burn, ibid., p. 546.
3. J. S. Flier, Proc. Natl. Acad. Sci. U.S.A. 94, 4242 (1997); N. Levin, C. Nelson, A. Gurney, R. Vandlen, F. de Sauvage, ibid. 93, 1726 (1996); M. A. Pelleymounter et al., Science 269, 540 (1995); J. L. Halaas et al., ibid., p. 543; L. A. Campfield, F. J. Smith, Y. Guisez, R. Devos, P. Burn, ibid., p. 546.
4. J. S. Flier, Proc. Natl. Acad. Sci. U.S.A. 94, 4242 (1997); N. Levin, C. Nelson, A. Gurney, R. Vandlen, F. de Sauvage, ibid. 93, 1726 (1996); M. A. Pelleymounter et al., Science 269, 540 (1995); J. L. Halaas et al., ibid., p. 543; L. A. Campfield, F. J. Smith, Y. Guisez, R. Devos, P. Burn, ibid., p. 546.
5. J. S. Flier, Proc. Natl. Acad. Sci. U.S.A. 94, 4242 (1997); N. Levin, C. Nelson, A. Gurney, R. Vandlen, F. de Sauvage, ibid. 93, 1726 (1996); M. A. Pelleymounter et al., Science 269, 540 (1995); J. L. Halaas et al., ibid., p. 543; L. A. Campfield, F. J. Smith, Y. Guisez, R. Devos, P. Burn, ibid., p. 546.
6. M. Shimabukuro et al., Proc. Natl. Acad. Sci. U.S.A. 94, 4637 (1997); T. Gainsford et al., ibid. 93, 14564 (1996); T. J. Kieffer, R. S. Heller, C. A. Leech, G. G. Holz, J. F. Habener, Diabetes 46, 1087 (1997); R. J. Zachow and D. A. Magoffin, Endocrinology 138, 847 (1997); J. A. Tuominen, P. Ebeling, M. L. Heiman, T. Stephens, V. A. Koivisto, Acta Physiol. Scand. 160, 83 (1997).
7. M. Shimabukuro et al., Proc. Natl. Acad. Sci. U.S.A. 94, 4637 (1997); T. Gainsford et al., ibid. 93, 14564 (1996); T. J. Kieffer, R. S. Heller, C. A. Leech, G. G. Holz, J. F. Habener, Diabetes 46, 1087 (1997); R. J. Zachow and D. A. Magoffin, Endocrinology 138, 847 (1997); J. A. Tuominen, P. Ebeling, M. L. Heiman, T. Stephens, V. A. Koivisto, Acta Physiol. Scand. 160, 83 (1997).
8. M. Shimabukuro et al., Proc. Natl. Acad. Sci. U.S.A. 94, 4637 (1997); T. Gainsford et al., ibid. 93, 14564 (1996); T. J. Kieffer, R. S. Heller, C. A. Leech, G. G. Holz, J. F. Habener, Diabetes 46, 1087 (1997); R. J. Zachow and D. A. Magoffin, Endocrinology 138, 847 (1997); J. A. Tuominen, P. Ebeling, M. L. Heiman, T. Stephens, V. A. Koivisto, Acta Physiol. Scand. 160, 83 (1997).
9. M. Shimabukuro et al., Proc. Natl. Acad. Sci. U.S.A. 94, 4637 (1997); T. Gainsford et al., ibid. 93, 14564 (1996); T. J. Kieffer, R. S. Heller, C. A. Leech, G. G. Holz, J. F. Habener, Diabetes 46, 1087 (1997); R. J. Zachow and D. A. Magoffin, Endocrinology 138, 847 (1997); J. A. Tuominen, P. Ebeling, M. L. Heiman, T. Stephens, V. A. Koivisto, Acta Physiol. Scand. 160, 83 (1997).
10. M. Shimabukuro et al., Proc. Natl. Acad. Sci. U.S.A. 94, 4637 (1997); T. Gainsford et al., ibid. 93, 14564 (1996); T. J. Kieffer, R. S. Heller, C. A. Leech, G. G. Holz, J. F. Habener, Diabetes 46, 1087 (1997); R. J. Zachow and D. A. Magoffin, Endocrinology 138, 847 (1997); J. A. Tuominen, P. Ebeling, M. L. Heiman, T. Stephens, V. A. Koivisto, Acta Physiol. Scand. 160, 83 (1997).
11. J. G. Mercer et al., FEBS Lett. 387, 113 (1996); C. Vaisse et al., Nature Genet. 14, 95 (1996).
12. J. G. Mercer et al., FEBS Lett. 387, 113 (1996); C. Vaisse et al., Nature Genet. 14, 95 (1996).
13. G. H. Lee et al., Nature 379, 632 (1996).
14. D. W. White and L. A. Tartaglia, Cytokine Growth Factor Rev. 7, 303 (1996).
15. H. Baumann et al., Proc. Natl. Acad. Sci. U.S.A. 93, 8374 (1996); N. Ghilardi et al., ibid., p. 6231; C. Bjøbæk et al., J. Biol. Chem. 272, 32686 (1997).
16. H. Baumann et al., Proc. Natl. Acad. Sci. U.S.A. 93, 8374 (1996); N. Ghilardi et al., ibid., p. 6231; C. Bjøbæk et al., J. Biol. Chem. 272, 32686 (1997).
17. H. Baumann et al., Proc. Natl. Acad. Sci. U.S.A. 93, 8374 (1996); N. Ghilardi et al., ibid., p. 6231; C. Bjøbæk et al., J. Biol. Chem. 272, 32686 (1997).
18. R. C. Frederich et al., J. Clin. Invest. 96, 1658 (1995).
19. D. L. Crandall, G. J. Hausman, J. G. Kral, Microcirculation 4, 211 (1997).
20. ext antibodies to extracellular epitopes of the leptin receptor.
21. M. R. Sierra-Honigmann et al., data not shown.
22. int, Ulex europaeus agglutinin I, or normal rabbit serum. After incubation with primary antibodies, tissue sections were developed with secondary horseradish peroxidase-conjugated goat antibody to rabbit IgG with a Vectastain Elite ABC kit (Vector Labs). The slides were counterstained with hematoxylin.
23. int (9) or with RC20 recombinant anti-phosphotyrosine (Transduction Laboratories, Lexington, KY).
24. 705) rabbit polyclonal antibody, was used for detecting the presence of Stat3 and phospho-Stat3 in the cell lysates.
25. 2, 20 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM phenytmethylsulfonyl fluoride, and a mixture of protease inhibitors]. After a 15-min incubation on ice, cells were homogenized, and nuclei were collected by centrifugation. The pellet was resuspended in low-salt buffer adjusted to 0.5 M KCl, extracted for 30 min at 4°C, and centrifuged at 25,000g for 30 min. Supernates were collected, dialyzed against buffer made 0.1 M with KCl, and divided into small portions kept at -80°C until used.
26. 32P-labeled probe for 20 min at room temperature in binding buffer [20 mM tris-HCl (pH 7.9), 50 mM NaCl, 1 mM EDTA, 10% glycerol, 0.1% NP-40, 1 mM DTT, bovine serum albumin (50 μg/ ml), and polydeoxyinosine/polydeoxycytosine (2 μg/ ml)]. Electrophoresis sample buffer was added to each sample before separation in a nondenaturing gel (89 mM tris, 89 mM boric acid, 10 mM EDTA, and 4.95% acrylamide). Gels were dried and exposed to autoradiography.
27. G. García-Cardeña, P. Oh, J. Liu, J. E. Schnitzer, W. C. Sessa, Proc. Natl. Acad. Sci. U.S.A. 93, 6448 (1996); V. Kundra, B. Anand-Apte, L. A. Feig, B. R. Zetter, J. Cell Biol. 130, 725 (1995).
28. G. García-Cardeña, P. Oh, J. Liu, J. E. Schnitzer, W. C. Sessa, Proc. Natl. Acad. Sci. U.S.A. 93, 6448 (1996); V. Kundra, B. Anand-Apte, L. A. Feig, B. R. Zetter, J. Cell Biol. 130, 725 (1995).
29. N. Ferrara and W. J. Henzel, Biochem. Biophys. Res. Commun. 161, 851 (1989).
30. R. K. Jain, K. Schlenger, M. Hockel, F. Yuan, Nature Med. 3, 1203 (1997); R. Auerbach, W. Auerbach, I. Polakowski, Pharmacol. Ther. 51, 1 (1991).
31. R. K. Jain, K. Schlenger, M. Hockel, F. Yuan, Nature Med. 3, 1203 (1997); R. Auerbach, W. Auerbach, I. Polakowski, Pharmacol. Ther. 51, 1 (1991).
32. 2 incubator at 37°C for 2 to 5 min, allowing them to solidify. Growth medium supplemented with endothelial cell growth supplement with or without human recombinant leptin was then added to each dish. Leptin was replenished every 24 hours. HUVECs were allowed to form tubelike structures for 2 days in culture and were then frozen and sectioned to a thickness of 40 μm. For immunofluorescence analysis, the sections were fixed with acetone (-20°C) and stained with tetramethylrhodamine isothiocyanate-labeled Ulex europaeus agglutinin I (0.5 μg/ml) and 4′,6′-diamidino-2-phenylindole (DAPI) (0.0001%).
33. V. P. Castle, V. M. Dixit, P. J. Polverini, Lab. Invest. 77, 51 (1997).
34. K. Koyama et al., Diabetes 48, 1276 (1997).
35. Y. T. Zhou et al., Proc. Natl. Acad. Sci. U.S.A. 94, 6386 (1997).
36. U. Sarmiento et al., Lab. Invest. 77, 243 (1997).
37. Abbreviations for the amino acid residues are as follows: C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
38. M. R. Sierra-Honigmann, J. R. Bradley, J. S. Pober, Lab. Invest. 74, 684 (1996).
39. We thank T. Buckholz and J. Kupcho for the synthetic peptides and conjugates, L. Friedman for the anti-leptin receptor, L. Benson and G. Davis for HUVEC cultures, D. O'Connor for help in migration studies, and J. Pober for laboratory resources.